VistaPath is modernizing pathology labs using computer vision and artificial intelligence. They provide clients with significant quality, workflow, and strategic benefits with the overall goal of delivering improved results for pathologists, clinicians, and patients. The Sentinel is the company's first product.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/01/22 | $4,000,000 | Seed |
First Star Venture Capital Moxxie  NextGen Venture Partners | undisclosed |
